Key terms

About ISRG

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ISRG news

Mar 26 4:51am ET Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), Regeneron (REGN) and Intuitive Surgical (ISRG) Mar 22 6:21am ET Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Intuitive Surgical (ISRG) and Bolt Biotherapeutics (BOLT) Mar 21 2:19am ET Intuitive Surgical’s Strong Outlook with New da Vinci 5: A Buy Rating from Mike Kratky Mar 19 9:50pm ET Analysts Are Bullish on Top Healthcare Stocks: Intuitive Surgical (ISRG), Tecan Group AG (TCHBF) Mar 19 8:20am ET Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG), CareMax (CMAX) and NovoCure (NVCR) Mar 19 7:37am ET UFP Technologies announces $500M amended supply agreement with Intuitive Surgical Mar 19 6:21am ET Analysts Offer Insights on Healthcare Companies: Biomea Fusion (BMEA), Intuitive Surgical (ISRG) and Sangamo Biosciences (SGMO) Mar 19 2:21am ET Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN), Intuitive Surgical (ISRG) and IN8bio (INAB) Mar 15 9:39am ET China stimulus positive for GE HealthCare, tool companies, says Evercore ISI Mar 14 4:42pm ET Intuitive Surgical Unveils FDA-Approved da Vinci 5 System Mar 14 4:35pm ET FDA clears Intuitive Surgical’s ‘fifth-generation robotic’ da Vinci 5 Feb 27 5:56am ET Intuitive Surgical: A Buy Rating with Sustained Growth and Strong Fundamentals Feb 06 1:50pm ET Intuitive Surgical Stock (NASDAQ:ISRG): Q4 Beat to Keep Fueling Gains Feb 06 7:50am ET Analysts’ Top Healthcare Picks: Intuitive Surgical (ISRG), Vertex Pharmaceuticals (VRTX) Feb 02 1:01am ET New Technology Risk for Intuitive Surgical – What’s the Latest? Jan 29 7:16am ET Analysts Are Bullish on These Healthcare Stocks: Intuitive Surgical (ISRG), Mach7 Technologies Ltd. (TDMMF) Jan 29 5:25am ET BTIG Sticks to Their Buy Rating for Intuitive Surgical (ISRG) Jan 26 12:42am ET Analysts’ Top Healthcare Picks: Intuitive Surgical (ISRG), Leap Therapeutics (LPTX) Jan 25 9:07am ET Intuitive Surgical price target raised to $375 from $330 at Morgan Stanley Jan 25 6:44am ET Intuitive Surgical price target raised to $390 from $350 at Mizuho Jan 25 5:35am ET Wall Street Analysts Are Bullish on Top Healthcare Picks Jan 25 5:28am ET Intuitive Surgical price target raised to $430 from $385 at Barclays Jan 24 3:10pm ET Intuitive Surgical (NASDAQ:ISRG) Clears 52-Week High, Da Vinci 5 May Be Coming Soon Jan 24 9:33am ET Intuitive Surgical price target raised to $432 from $400 at RBC Capital Jan 24 8:24am ET Intuitive Surgical price target raised to $435 from $390 at Truist Jan 24 8:11am ET Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG) and Urogen Pharma (URGN) Jan 24 8:08am ET Intuitive Surgical price target raised to $385 from $335 at Evercore ISI Jan 24 7:41am ET Analysts Conflicted on These Healthcare Names: Intuitive Surgical (ISRG), Madrigal Pharmaceuticals (MDGL) and Doximity (DOCS) Jan 24 7:30am ET Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), GoodRx Holdings (GDRX) and Intuitive Surgical (ISRG) Jan 24 7:26am ET Intuitive Surgical price target raised to $425 from $325 at Piper Sandler Jan 24 7:21am ET Intuitive Surgical price target raised to $420 from $360 at Stifel

No recent press releases are available for ISRG

ISRG Financials

1-year income & revenue

Key terms

ISRG Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ISRG Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms